Kilitch Drugs (India) shareholding pattern
KILITCH
313.85
3.95 (-1.24%)Last updated on 20 Feb, 2026 | 15:47 IST
BUYSELL
Free Demat with Zero AMC*
Summary
For Year 2025-26, Kilitch Drugs (India) reports the following shareholding: Total Promoters at 63.77%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 36.23%. This breakdown provides a quick snapshot of ownership distribution for Kilitch Drugs (India) in 2025-26.
Kilitch Drugs (India) FAQs
As of 02-2026, the promoter shareholding in Kilitch Drugs (India) stands at 63.77% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Kilitch Drugs (India) is 0% and 0% respectively.
The retail shareholding of the Kilitch Drugs (India) is 36.23%.
Changes in shareholding patterns of Kilitch Drugs (India) can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Kilitch Drugs (India) are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Kilitch Drugs (India) Associated Pages
